ArticleSurgical case reports2025

Effusion Reduction after Early Trastuzumab Deruxtecan Therapy for Unresectable HER2-Low Breast Cancer in an Older Patient: A Case Report.

Ayaka Akabane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.